Clinical Trial Update: Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial examining the biodistribution of the Ga-68 labeled imaging tracer 68Ga-FAPi-46 in patients with solid tumors and hematologic cancers. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Bladder Cancer
• Breast Cancer
• Cervical Cancer
• Colorectal Cancer
• Esophageal Cancer
• Head and Neck Cancer
• Lung Cancer

Drugs mentioned

• 68Ga-FAPI-46 (Gallium-68-labeled FAPI-46)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Anal Carcinoma, Bladder Carcinoma | Phase 1 | Status: RECRUITING